Your Article Summary
See Latest ArticlesNo Role for Cerebrospinal Fluid Myelin Basic Protein Levels in Patients Treated for Childhood Acute Lymphoblastic Leukemia
Journal of Pediatric Hematology/Oncology, 07/01/09
Diezi M et al. - Notwithstanding the retrospective character of this study, authors conclude that there is limited usefulness of systematic dosage of MBP as indicator of treatment-induced neurotoxicity in acute lymphoblastic leukemia patients.
Related Articles
Detection and Clinical Relevance of BCR-ABL Fusion Gene in Childhood T-lineage Acute Lymphoblastic Leukemia
Journal of Pediatric Hematology/Oncology, 11/30/09
Relevance Score: 81%
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
Blood, 11/13/09
Relevance Score: 81%
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993)
Blood, 11/02/09
Relevance Score: 81%
Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09
Relevance Score: 81%
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F-protocol
Pediatric Blood & Cancer, 10/09/09
Relevance Score: 81%
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical features and surgical outcome of a suprarenal mass detected before birth
Pediatric Surgery International, 12/04/09
Radiation Dose and Excess Risk of Cancer in Children Undergoing Neuroangiography
American Journal of Roentgenology, 12/04/09
Preimplantation genetic diagnosis for haematologic conditions
Current Opinion in Pediatrics, 12/04/09